macular edema therapy using dexamethasone nanoparticle suspension

macular edema therapy using dexamethasone nanoparticle suspension PURPOSE To determine the effectiveness and safety of a new topical nanoparticle dexamethasone ophthalmic suspension OCS-01 (Oculis SA, Lausanne, Switzerland) in the treatment of diabetic macular edema (DME). STUDY BACKGROUND Diabetic macular edema (DME) is the main cause of visual impairment in patients with diabetic retinopathy (DR).

Using Nanofiber Antibiotic Sutures Prevent Ophthalmic Infections

Using Nanofiber Antibiotic Sutures to Prevent Ophthalmic Infections Sutures are medical devices applied on the site of injury or surgery. Sutures prevent infection, minimize scarring, and fasten recovery. As of today, the only drug-eluting sutures available for antibacterial application in most surgeries are coated with >triclosan. It’s known that putting drugs

The Future of Glaucoma Therapy? Microneedles and the Reduction of Intraocular Pressure

The Future of Glaucoma Therapy? Microneedles and the Reduction of Intraocular Pressure Around 75 million people suffer from glaucoma, making it the world’s leading eye disorder that causes irreversible blindness. Vision loss in glaucoma patients is often accompanied by the dysfunction of the retinal ganglion cell axons. This is believed to

Use of nanotechnology to deliver topical ophthalmic medications

nanotechnology medicine

Use of nanotechnology to deliver topical ophthalmic medications Topical drug delivery systems are widely used in transdermal, mucous membrane, ophthalmic, and otic applications as they are highly versatile, effective, and convenient. However, medication delivery complications such as drug solubility, bioavailability, timed release, and inaccurate physical targeting do exist. Recent advancements in nanotechnology

Dry Eye Disease and Dehydration